January 10, 2025 - 03:33

In a comprehensive industry outlook for 2025, key trends have emerged that are set to shape the aviation finance landscape. Notably, there is an anticipated resurgence in lease rates, which reflects a growing confidence among market stakeholders. This uptick is expected to stimulate investment and drive demand for aircraft financing options.
Another significant development is the transition from LIBOR to SOFR, which marks a pivotal shift in how financial agreements are structured. This change is likely to affect pricing and risk management strategies across the aviation sector.
Additionally, the aircraft asset-backed securities (ABS) market is showing signs of recovery, indicating renewed investor interest and a more favorable environment for financing aircraft through securitization. These trends collectively suggest a more optimistic outlook for aviation finance as the industry adapts to evolving economic conditions and regulatory frameworks. Stakeholders are advised to stay informed and agile to capitalize on these emerging opportunities in the coming years.
July 12, 2026 - 04:45
Paramount–Warner Bros. merger could make HBO Max a 'staple'Wall Street is still waiting for the Paramount and Warner Bros. Discovery merger to close, but analysts are already betting on how the combined company will reshape the streaming landscape....
July 11, 2026 - 08:53
$9.5 Billion Focus Financial Network Expands to East Coast with Advisor Jennifer McDonaldMINNEAPOLIS, July 10, 2026 -- Focus Financial Network, a wealth management firm overseeing $9.5 billion in client assets, has expanded its footprint to the East Coast by adding financial advisor...
July 10, 2026 - 21:34
What the housing affordability bill means for buyers and sellersA new bipartisan bill in Congress, the 21st Century ROAD to Housing Act, is aiming to tackle the nation`s affordability crisis head-on. The legislation targets three main pain points: a severe...
July 10, 2026 - 09:43
MindRank Announces $52 Million Series B FinancingMindRank AI Ltd., a clinical-stage biotechnology company based in Hangzhou, China, has announced the completion of a $52 million Series B financing round. The funding was led by a group of...